Menu
Log in
Forgot password



Your Resource for Neurotherapeutics Discovery and Development


Log in
  • Home
  • Annual Meeting

Annual Meeting Overview

Join us as the American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2026) will be held at Hyatt Regency Bethesda, in Bethesda, MD from March 2-6, 2026. 

Neurotherapeutics Clinical Trials Course: March 2-3, 2026
Annual Meeting scientific program: March 4-6, 2026

ASENT's 2026 Annual Meeting is the premier neuroscience and neurotherapeutics conference where senior leaders from healthcare payers, providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centers gather to improve the process of bringing neurotherapeutics to market.

The Meeting features 9 symposia, which address therapeutic advances in a broad range neurologic disease states, processes and delivery methods; as well as interactive poster presentations, ASENT's celebrated pipeline presentations, and live discussion with speakers at the end of each day. 

2026 Meeting Highlights 

    • 9 Scientific Symposia featuring Neuroscience leaders from Industry, Academia, FDA, NIH, and Advocacy
    • Industry Roundtable
    • CNS Pipeline Presentations
    • Interactive Poster Discussions
    • Sponsored Symposia from Innovation Leaders
    • Live Discussions in Breakout Rooms with Speakers
    • 3rd Annual Neurotherapeutics Clinical Trial Course - LIVE 

    Meeting Location

    Hyatt Regency Bethesda, Bethesda MD

    Who Attends

    30% Academia / 30% Industry / 30% Government / 10% Advocacy

    50% of attendees are practicing physicians

    Physician-Scientists | Neurologists | Neuroscientists | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA

    The 2026 meeting will feature a high number of junior faculty and trainees as attendees at our clinical trials course and neurotherapeutic drug discovery course are welcome to attend the annual meeting at a discounted cost. 

    Neurology students and residents interested in neurotherapeutic development will benefit from the insight of senior investigators and leaders in industry, while private practice neurologists considering entering the clinical trial space will benefit from lessons learned by ASENT leadership. The Annual Meeting features career development sessions that offer strategies for achieving professional success in the field of neurotherapeutics. 

    Registration Rates

    Cancellation Policy

    You may cancel your registration for a refund through February 1, 2026. Cancellations will be refunded less a $50 cancellation fee. No refunds will be granted for cancellations on February 14, 2026, and after.


    Upcoming events

    • 2026 Abstract Submissions

      • November 24, 2025
      • ? - 11:59 PM
      • Hyatt Regency Bethesda, Bethesda MD
      Register

      Submitting an Abstract to ASENT

      Deadline Extended: November 24, 2025 at 11:59PM ET

      The Abstract Review Committee is committed to presenting the best in neurotherapeutic research at the ASENT Annual Meeting. All abstracts are evaluated by experts in neurotherapeutics according to the following criteria and overall merit:

      1. Scientific or clinical impact
      2. Quality of data, analysis, and presentation
      3. Relevance to the discovery and/or development of neurotherapeutics and inclusion of novel targets or new initiatives.
      4. Abstracts must be submitted, presented, and cited in English.

      The abstract should describe original research broadly relevant to the goal of ASENT, which is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system. Please check your abstract carefully for typographical errors, misspellings, etc. Be sure to include data results.

      FAQs on Eligibility

      • ASENT welcomes Encore Abstracts, or those abstracts that have been previously presented at other recent scientific meetings, or submitted for consideration to other scientific meetings.
      • Trainees and early career researchers are encouraged to submit
      • All sectors (academic, industry, government, etc.) are welcome to submit
      • Trial Designs or Trials in Progress are welcome and considered 
      • Case Studies or Case Reports will not be considered

      If Accepted

      One presenting author must be designated to attend the Annual Meeting in person. All attendees must register to attend the meeting via asent.org separate from this form. 

      Poster Presentations
      If your abstract is selected for a poster, you will need to be available to participate in our poster presentation at the annual meeting. This is scheduled to take place on Wednesday, March 4, 2026 at 5pm.

      Oral Presentations
      Submitted abstracts that most closely conform to the above criteria, and the ASENT goals, may also be selected for a 10-minute oral presentation (including 2 minute Q&A) at our Oral  Presentation session. ASENT encourages abstracts from private, public and startup companies and government or academic labs that contain neurotherapeutic research results.

      About the Meeting
      The ASENT Annual Meeting attracts a broad spectrum of researchers, clinicians, investors, and other leaders in neurotherapeutics from all over the world, in all neurologic disease states. Oral presentations increase exposure to strategic partners in life sciences who have supported novel approaches through partnerships or strategic investments.

      For questions regarding abstracts, please email jessica@asent.org.

      Show details

    • ASENT 2026 Annual Meeting and Clinical Trials Course

      • March 02, 2026
      • 8:00 AM
      • March 06, 2026
      • 1:00 PM
      • Hyatt Regency Bethesda, Bethesda, MD
      Register

      ABOUT the MEeting

      Neurotherapeutic Clinical Trials Course: March 2-3, 2026
      ASENT 2026 Annual Meeting: March 4-6, 2026

      The ASENT 2026 Annual Meeting and Clinical Trials Course, the premier neurotherapeutics conference will take place March 2 - 6, 2026 at the Hyatt Regency Bethesda in Bethesda, MD. This scientific meeting is where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather with one central focus, improving the process of bringing neurotherapeutics to market.

      Advance Program Submit an Abstract Register Clinical Trials Course Exhibit Opportunities


      ASENT's popular Neurotherapeutic Clinical Trials Course runs March 2-3. Followed by the ASENT 2026 Annual Meeting, which runs March 4-6, all in one location.

      Attendees interested in participating in both the Clinical Trials Course and Annual Meeting are encouraged to select the appropriate registration level and then add on the clinical trials course during the registration process for an additional $150.

      The plenary sessions, panel discussions, outstanding pipeline presentations and poster sessions focus on the latest science in neurotherapeutics. The conference content will focus on the latest science in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices. The event features plenary sessions, panel discussions, satellite luncheons, networking meetings, pipeline presentations and poster sessions.

      WHO ATTENDS

      Chief Medical Officers | Chief Scientific Officers | Clinician-Investigators | Clinical Research Professionals | Clinical Scientists Clinical Trial Unit Directors | CROs | Drug Discovery Neuroscientists  Founders | Funders | Innovation Centers | Investors / Venture Capital | Journal Editors | Medical Directors | MSLs | Patient Advocates | Regulatory Science Professionals | Research Scientists | Trainees (Basic, Clinical, Translational)

      Show details
    Powered by Wild Apricot Membership Software